UnitedHealth Under DOJ Scrutiny: Allegations of Medicare Fraud Surface
UnitedHealth Group faces a DOJ probe over potential Medicare fraud, asserting its compliance and accuracy record while initiating third-party reviews for transparency.
UnitedHealth Group faces a DOJ probe over potential Medicare fraud, asserting its compliance and accuracy record while initiating third-party reviews for transparency.
UnitedHealth Group's shares fell sharply by 16% after reports emerged of a DOJ criminal investigation into its Medicare billing practices, focusing on the Medicare Advantage busine...
The DoJ is investigating UnitedHealth Group for possible Medicare fraud, focusing on its Medicare Advantage practices. This adds to the company's challenges, including stock price ...
UnitedHealth Group's stock fell over 12% after announcing CEO Andrew Witty's departure and the return of former CEO Stephen Hemsley, alongside suspending its 2025 forecast due to r...
UnitedHealth Group Inc. shares fell over 20% in premarket trading after revising its forecast downward, attributing the adjustment to rising medical care costs among older adults. ...
UnitedHealth Group Inc. shares plummeted over 20% in premarket trading after revising its earnings forecast downward, citing rising medical costs. The company's leadership vows cor...
UnitedHealth Group Inc. sees a 20% premarket drop after revising its 2025 forecast due to rising healthcare costs. The company faces Senate scrutiny over Medicare billing practices...
UnitedHealth Group Inc. shares fell over 20% in premarket trading after revising its forecast due to rising medical costs among older adults, amid a Senate inquiry into its Medicar...
UnitedHealth Group Inc. shares plummet over 20% in premarket trading after revising its forecast due to rising medical costs among older adults, amidst leadership challenges and a ...
UnitedHealth Group Inc. shares plummeted 20% in premarket trading after revising its forecast due to rising medical costs among older adults, amid a Senate inquiry and the tragic l...
UnitedHealth Group Inc. shares plummeted 20% in premarket trading after cutting its forecast due to rising medical costs among older adults, amidst regulatory scrutiny and the trag...
UnitedHealth Group Inc. sees a 20% stock drop due to rising medical costs and faces legal scrutiny. CEO Andrew Witty outlines corrective steps, while the company deals with the tra...
UnitedHealth Group Inc. reported a 10% increase in Q1 2025 revenue to $109.6 billion, missing estimates but marking a significant turnaround from last year's losses. Despite the gr...
UnitedHealth Group Inc. reports a 6% revenue increase to $100 billion in Q4 2024, with net earnings up by 1.9%. Despite missing analysts' expectations, the company shows resilience...